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Zizyphus spina-christi (Rhamnaceae) grows wild in tropical Africa and Asia and can be domesticated. It 
has folkloric usage in pain related ailments throughout these regions. In view of the claimed therapeutic 
potentials, investigation of the plant’s root bark was initiated in our laboratory. The plant material was 
first sequentially extracted with hexane, chloroform, ethylacetate and methanol, and in this report, a 
fraction (numbered) ZS-4D from the methanol extract eluted with 70:30% (chloroform : methanol) using 
flash column chromatography was apparently traced to be responsible for its main analgesic, and in 
addition, anti-inflammatory activities. The fraction (25, 50 and 100 mg/kg, i.p.) was tested on chemical 
(acetic acid-induced writhing, formalin), mechanical (analgesy-meter) and thermal (tail-flick) analgesic 
tests with the aim of elucidating both central and peripherally mediated action in rats and mice. Its anti-
inflammatory action against egg albumin-induced hind paw oedema was also tested in rats. Results 
show that the fraction has some levels of dose related effect on all the models except the tail-flick test 
in which the activity was not statistically significant.  
 





Traditional herbal remedies have a long and popular 
usage in treatment of pain related ailments (Almeida et 
al., 2001). Interestingly, the World Health Organization 
have recommended the integration of traditional medi-
cines proved to be useful into national health care progra-
mmes (WHO, 1976), set up guidelines for its study 
(WHO, 1991; 2001) and defined its role under what it 
termed ‘Traditional Medicine/Complementary and Alter-
native Medicine (TM/CAM)’ by developing a strategy to 
address issues of policy, safety, efficacy, quality, access 
and rational use (WHO Traditional Medicine Strategy 
2002-2005). Traditional medicine practice is most popular 
in developing countries (Elisabetsky, 1991) and unique in 
its own way because it takes a holistic view of the 
patient’s situation (Jager, 2005). Several bioactive agents 
in modern  pharmacopoeia  were  derived  from  products 
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Astin, 1998; De Smet, 1998; De Silva, 2005). In view of 
the popular and widespread use of herbal products used 
in such practice, important technical aspects such as 
standardization and quality control need development 
(Fansworth, 1980; Bonati, 1991; De Smet, 1991; 
Elisabetsky and Shanley, 1994; Patwardhan, 2005), 
since some are suspected to be interacting with synthetic 
drugs (Ernst, 2000).  
Zizyphus spina-christi Willd (Rhamnaceae) is a plant 
that grows wild in Asia and tropical Africa. The plant is 
originally of the Middle East south of the Euphrates and 
spread to Saharan Oases across Africa into the Sahel 
(Burkill, 1997). It has several physiological and morpholo-
gical characteristics (Keay et al., 1964) that assures its 
ability to adopt to arid environment. It derived its name 
from kinnara, a sweet edible fruit produced from Krists’ 
thorn tree, one of the prickly/thorny shrubs found in 
Palestine believed to have been used for Christ’s crown 
of thorns (Arndt, 2000). The plant has versed medicinal 
and nutritional values (Dalzell, 1937; Hutchens, 1973; 
Duke,  1985;  Al-Yahya,  1986;  Eden  Foundation,  1992;  




Burkill, 1997; Al-Khalifa and Al-Arify, 1999). It was 
reported to exhibit antibacterial, anticancer, antidiabetic, 
anti-nociceptive, antihypertensive, antidiarrhoeal and 
CNS effect from previous studies (Fleurentin and Pelt, 
1982; Friedman et al., 1986; Tanira et al., 1988; Shah et 
al., 1989; Hussain and Deeni, 1991; Glombitza., 1994; 
Ali-Shtayeh et al., 1998; Ali et al., 2001; Shahat et al., 
2001; Adzu et al., 2001, 2002a, 2003; Lev and Amar, 
2002; Nazif, 2002; Abdel-Zaher et al., 2005; Adamu et 
al., 2005; Abdel-Wahhab et al., 2007). Some useful phyt-
ochemicals that include flavonoid, tannins, lipids, terp-
enes, alkaloids, steroids and carbohydrates have been 
isolated from the plant (Grindley, 1948; Aynehchi and 
Mahoodian, 1973; Tschesche et al., 1974; Ikram and 
Tomlinson, 1976; Tawfik et al., 1978; Rizk, 1982; Ali et 
al., 1985; Al-Yahya, 1986; Shah et al., 1986; Abdel Galil 
and El-Jissry, 1991; Mahran et al., 1994; Weinges and 
Schick, 1995; Shahat et al., 2001).  
Among the popular use of Zizyphus spina-christi in tra-
ditional medicine is in the treatment of pain and inflam-
matory related ailments across regions in which the plant 
grows. This includes Saudi Arabia (Shah et al., 1989; Al-
Said, 1993), Oman (Ghazanfar and Al-Sabahi, 1993), 
Israel (Friedman et al., 1986), northern Nigeria (Adzu et 
al., 2001) and a related specie (Z. jujuba) used in Japan 
(Watanabe et al., 1973; Shibata and Fukushi, 1975; 
Morishita et al., 1987). Of recent, we initiated fraction-
alization and pharmacological evaluation of useful com-
ponents of the plant’s root bark in line with the 31st WHO 
Assembly involving inventory, evaluation and standard-
ization of traditional medicines (Farnsworth, 1980). A 
previous study (Adzu et al., 2001), which suggested 
potent anti-nociceptive activity prompted this work. In this 
report, we presented the potentials of a fraction (numb-
ered ZS-4D) against pain and inflammatory models in 
rats and mice. The root bark was first sequentially extra-
cted with four solvents along increasing polarity to give 
hexane (ZS-1), chloroform (ZS-2), ethylacetate (ZS-3) 
and methanol (ZS-4) extracts using a soxhlet extractor 
(Quickfit, England). The extracts were preliminary tested 
via monitoring of analgesic activity and methanol extract 
(ZS-4) gave most potent effect. The methanol extract was 
fractionated using flash column chromatography (Still et 
al., 1978), and the fraction (ZS-4D) eluted with 70:30% 
(chloroform: methanol) was evaluated using chemical 
(acetic acid-induced writhing and formalin test), thermal 
(tail-flick) and mechanical (analgesy-meter) pain models. 
Its anti-inflammatory potential was assayed using egg 
albumin-induced oedema as the in vivo model of inflam-
mation. The phytochemical constituent as well as the 
safety of the methanol extract was also tested. 
 
 









State, Nigeria between April and May, 2004. It was authenticated at 
Taxonomy Unit, Department of Medicinal Plant Research and 
Traditional Medicine, National Institute for Pharmaceutical Resear-
ch and Development (NIPRD), Abuja, Nigeria. A voucher specimen 
(NIPRD #4108) was deposited at the herbarium of the Institute. The 
root bark of the plant was carefully removed, cleaned and dried 
under shade. The dried root was grounded into powder and 1.29 kg 
of the powdered material sequentially extracted to obtain hexane 
(ZS-1), chloroform (ZS-2), ethylacetate (ZS-3) and methanol (ZS-4) 
extracts. The combined extract of each solvent was concentrated 
and evaporated to dryness. It gave yields of 4.623, 27.834, 4.443 
and 245 g for hexane, chloroform, ethylacetate and methanol 
extracts respectively. The total yield of the extracts was 21.86% 





Phytochemical constituents present were screened using standard 
procedures (Harborne, 1998; Evans, 2002). TLC was carried out to 
determine spot zones which were viewed under UV light (254/365 
nm Eagle Scientific Limited, UK). 
 
 
Flash column chromatography 
 
Twenty grams of the methanol extract (ZS-4) was mixed with 20 g 
of silica gel (Aldrich Chemicals; 230-400 Mesh) and loaded on top 
of a flash column (Still et al., 1978) containing another 150 g of 
silica gel. It was flush with hexane, and eluted in increasing polarity 
with hexane, combinations of chloroform and methanol, and metha-
nol in multiples of 100 ml using an air pump (ABM, Germany). Each 
of the fractions consisting of 100 ml was individually collected. A 
total of 73 fractions were collected. Fractions detected to contain 
the same product using TLC were combined together, concentrated 
over water bath, and allowed to evaporate at room temperature. 
This results in 6 fractions (ZS-4A to ZS-4F). Fraction ZS-4D eluted 
with 70:30 (chloroform: methanol) which presented both analgesic 
and anti-inflammatory activity according to analgesic activity 
monitoring was thus fully investigated. 
 
 
Vacuum column chromatography 
 
The chromatography (O’Donnell et al., 2006) was carried out using 
Sinta funnel (Quickfit, England) attached to an air pump (ABM, 
Germany) to get enough of the fraction (ZS-4D) for pharmacological 
studies. Eighty grams of the methanol extract (ZS-4) was mix with 
60 g of silica gel and flush with mixture of 75:25 (chloroform: 
methanol) followed by elution of 2l of the fraction of interest that is, 
70:30 (chloroform:methanol). It was concentrated over water bath 





Swiss albino mice and Wistar rats of both sexes obtained from 
Animal Facility Centre, NIPRD, Abuja, were used for the study. 
They were housed in plastic cages with saw dust as beddings and 
given food and water ad libitum. The mice were used in accordance 
with NIH Guide for the Care and Use of Laboratory Animals; 
published by the US National Institute of Health-NIH Publication 
(No 83-23) revised (1985), ethical guidelines for investigation of 
experimental pain in conscious animal (Zimmermann, 1983) and 
NIPRD’s in-house Standard Operation Procedures (NIPRD-SOPs) 





Chemicals, drugs and test agents 
 
All the chemicals used for the extraction, fractionalisation and 
chromatography (hexane, chloroform, ethylacetate and methanol) 
were of analytical grade and were purchased from Sigma-Aldrich 
sales representative in Nigeria (Zayo International Limited, Jos, 
Nigeria). Other chemicals used are formaldehyde, Triton-X and 
acetic acid (BDH, England). Three dose levels of the fractions (25, 
50 and 100 mg/kg, i.p.) were used throughout the study. The nega-
tive control received normal saline (10 ml/kg, i.p.) while acetylsa-
licylic acid (ASA) (100 mg/kg, i.p.) (Osadepe and Okoye, 2003) 
served as the positive control. ASA was chosen for the fact that it 
has anti-nociceptive action independent of their anti-inflammatory 
effect which does not have any delay of onset of action (Capetola et 
al., 1983; Hunskaar et al., 1985, 1986, 1987). The fraction (ZS-4D) 
was completely soluble in water. 
 
 
Acute toxicity test 
 
The safety of the methanol extract (ZS-4) was tested using Lorke’s 
method (1983). Briefly, the extract was administered in geometric 
doses of 10, 100, 1000 and 2000 mg/kg, i.p. to four groups of mice. 
Another mouse was given normal saline to serve as the control and 
all the mice were kept under same conditions and observed for 
toxic signs, and mortality within 24 h was noted as index of acute 
toxicity. LD50 was estimated from the square root of the lowest 
lethal dose and the highest non-lethal dose (Osadepe and Okoye, 
2003; Vongtau et al., 2004). 
 
 
Acetic acid-induced writhing 
 
The test was carried out using the methods described by Koster et 
al. (1959) and Collier et al. (1968). Two sets (1 and 2) of five groups 
of mice (n = 5) were pretreated with ZS-4D, saline and ASA. Each 
mouse was injected with 0.7% of an aqueous solution of acetic acid 
(10 ml/kg, i.p.) after the predetermined time (30 and 60 min for sets 
1 and 2 respectively) and placed in transparent observational cage. 
The number of writhes (abdominal constriction) exhibited by each 
mouse was cumulatively counted for 15 min after 5 min (lag time) of 
the aqueous acid injection (Loro et al., 1999) and the mean count of 





Dubuission and Dennis (1977) method modified by Tjolsen et al. 
(1992) was adopted. Five groups of rats (n = 5) were pretreated 
with either the fraction, saline or ASA. They were injected s.c. with 
50 µl of 2.5% solution formalin into the sub-plantar surface of rat left 
hind paw 30 min after the treatment. Severity of pain was rated in 
two distinct phases for 1 h; the first phase (0 – 10 min) taking every 
two min and late phase (15 – 60 min) every 5 min using 3 promi-
nent pain-induced behaviour in the following scoring manner: (0) 
normal weight baring on the injected paw; (1) light resting on the 
paw on the floor; (2) elevation of the injected paw and (3) for licking, 
biting or grooming of the injected paw. The mean (±SEM) of the 





The experiment was carried out using Ugo Basile Analgesy-Meter 
(No. 7200) on normal rats as described by Vongtau et al. (2004). 
Twenty five rats were grouped into five (n = 5) and treated with 
saline, ZS-4D or ASA. The rat paw was placed on a plinth under a 
cone-shaped pusher of the instrument and increased pressure app- 




lied to the middle dorsum of the rat’s left hind paw (Chipkin et al., 
1983; Kitchen, 1984; Nguelefack et al., 2004). Stimulus was termi-
nated and force threshold readings in grams (Anseloni et al., 2003) 
taken as soon as nociceptive response were elicited by the rats 
(Iwalewa et al., 2003; Srinivasan et al., 2003). Readings were 
taking at 0, 15, 30 and 60 min after treatment. 
 
 
Tail-flick test  
 
The study (D’Amour and Smith, 1941), as subsequently modified for 
rats using hot water bath (Janssen et al., 1963; Asongalem et al., 
2004a, 2004b; Rabanal et al., 2005; Sanchez-Mateo et al., 2006) 
was adopted with minor modification for our local laboratory 
settings. The test was carried out by immersing the terminal 2 cm of 
the rat tail in hot water contained in a 500 ml beaker maintained at 
55 ± 1oC using a hot plate (Ugo Basile, Socrel DS-37). A thermo-
meter was placed inside the water to monitor the temperature 
reading. Twenty five rats that shows response (withdrawing the tail) 
within 3s were selected and grouped into five (n = 5). The rats were 
then treated with either ZS-4D, saline or ASA and their responses 





In this procedure, fresh undiluted egg albumin was used as in vivo 
model of acute inflammation in rats (Akah et al., 1993). The rats 
were divided into five groups (n = 5) and treated with saline, ZS-4D 
or ASA. Oedema was then induced 30 min later in the rats by sub-
plantar injection of 0.1 ml of raw egg-albumin to the left hind paw 
and oedema volume measured with a LETICA (Spain) digital 
plethsmometer (LE 7500) calibrated with 0.1% Triton X-100. 
Readings were taken 5 min later in an interval of 20 min for a total 





Results were expressed as mean ± standard error of mean (SEM). 
Student t-test was used to analyze level of statistical significance 
between groups and Analysis of Variance (ANOVA) among groups. 





The methanol extract of the extract (ZS-4) gave positive 
test for balsams, carbohydrates, saponins and tannins. 
The extract produced 100% lethality in doses higher than 
900 and 0% in doses below 700 mg/kg, i.p. in the second 
phase of dosing. The LD50 was thus established to be 
793.74 mg/kg, i.p. Tremor, then sedation was observed 
as the acute sign of toxicity. Convulsion preceded death 
in a mouse among the group that received 200 mg/kg, 
i.p. of the extract. 
The tested fraction (ZS-4D) exhibited significant F [(4, 
24) = 3.8; p < 0.05] inhibition of the abdominal writhing 
(writhing/15 min) induced by acetic acid dose depend-
ently. The potency was observed at both 30 and 60 min 
pre-treatment (Table 1). Results of the formalin test 
shows that the fraction inhibited the formalin noxious 
stimulation on both the aphasic (first) and the tonic (sec-
ond) phases of the test. More of the inhibition was  obser- 




Table 1. Effect of Zizyphus spina-christi ZS-4D fraction on acetic acid-induced writhing 
(mean ± SEM/15 min) in mice. 
 
Treatment        Dose (mg/kg, i.p.) 30 min 60 min 
Control  - 39.0 ± 3.4 36.2 ± 2.9 
ZS-4D 25 31.4 ± 2.2 32.8 ± 2.7 
 50 21.0 ± 1.9 19.4 ± 2.0 
 100 15.0 ± 2.1 13.0 ± 1.2 




Table 2. Effect of Zizyphus spina-christi ZS-4D fraction on formalin induced noxious stimulus scorea (mean 
± SEM) test in rats. 
 
Treatment        Dose (mg/kg, i.p.) First phase (0-10 min)  Second phase (15-60 min) 
Control  - 2.6 ± 0.2 2.6 ± 0.1 
ZS-4D 25 2.2 ± 0.2 2.1 ± 0.2 
 50 2.0 ± 0.3  1.9 ± 0.2 
 100 1.4 ± 0.2 1.4 ± 0.1 
ASA 100 2.0± 0.3 0.9 ± 0.1 
 




ved in the late phase for the ASA group (Table 2). The 
fraction was also potent in the analgesy-meter test, with 
the animals showing an increased threshold to the 
pressure when compared with the control (Table 3). The 
fraction however failed to exhibit significant effect in the 
tail-flick test (Table 4). 
The pre-treated fraction as well as ASA produced 
significant F [(4, 24) = 2.9; p < 0.05] activity against the 
inflammation processes induced by egg-albumin, which 
was maintained throughout the 120 min duration of the 
experiment. In contrast, there is a consisted increase in 






We have shown in previous study that the crude aqueous 
extract of Z. spina-christi exhibited anti-nociceptive 
potency with both central and peripheral effect (Adzu et 
al., 2001). The plant has been implicated in the folkloric 
treatment of inflammatory and pain related ailments 
(Friedman et al., 1986; Shah et al., 1989; Al-Said, 1993; 
Ghazanfar and Al-Sabahi, 1993). In this study, we 
fractionated the extracts of the plant material and trace 
the main analgesic and in addition, an anti-inflammatory 
activity to either fraction (numbered) ZS-4D eluted with 
70:30 (chloroform : methanol) along or in combination 
with components of methanol extract of the root bark. 
Although there are some advantages to the medical use 
of extracts as oppose to isolated entities (Phillipson, 
2001), there is the need to get to the closest of which 
component is responsible for the observed effect 
(Farnsworth, 1980). Such search for analgesic agents 
have been a priority of some pharmaceutical industries 
for some time now (Mattison et al., 1988), and plant 
sources are one of the logical and productive strategies, 
especially for the fact that important analgesic prototypes 
like salicyclic acid and morphine were originally derived 
from plant kingdom (Elisabetsky et al., 1995). The experi-
mental models were chosen in such a way that the 
existence of both central and peripherally mediated pain 
relief could be measured.  
The results show that the fraction exhibited potent 
analgesic activity against aqueous acetic acid-induced 
writhing. The acid produces abdominal writhing response 
in animals through chemosensitive nociceptors by 
increasing fluids of PGE2 and PGF2 (Daraedt et al., 
1980) and sympathetic nervous system mediators 
(Duarte et al., 1988; Barsato et al., 2000) leading to 
production of algogenic substances at the peritoneal 
receptors (Bentley et al., 1983). The test is a sensitive 
procedure in detecting analgesic effects of medicinal 
substances and can detect antinociceptive effect that 
may appear inactive in other methods (Collier et al., 
1968; Bently et al., 1981). However, the test cannot 
indicate the exact mechanism of analgesic effect of test 
substances (Stai et al., 1995) with false positive occurring 
with agents like sedatives (Elisabetsky et al., 1995). The 
fraction gave a similar effect on the formalin test inhibiting 
both the first and the second phase. Formalin test is 
biphasic, and measures pain of both neurogenic (first 
phase) and of inflammatory origin (second phase). The 
first phase (0 – 10 min) being a result of direct stimulation 
of nociceptors measures centrally mediated effects and is 
insensitive to anti-inflammatory agents while the second 
phase (15 – 60 min) which  is  qualitatively  different  from 




Table 3. Effect of Zizyphus spina-christi ZS-4D fraction on analgesy-meter in rats. 
 
Threshold (mean ± SEM X 20 g) Treatment        Dose (mg/kg, i.p.) 
0 min 30 min 60 min 
Control  - 4.0 ± 0.5 3.3 ±0.5 3.8 ± 0.8 
ZS-4D 25 3.2 ± 0.3 6.9 ± 0.4 8.3 ± 0.7 
 50 3.9 ± 0.4 8.7 ±0.6 11.3 ± 0.9 
 100 2.8 ± 0.5 12.2 ± 1.01 5.4 ± 1.4 




Table 4. Effect of Zizyphus spina-christi ZS-4D fraction on thermal stimulus stimulus-induced 
tail-flick test (withdrawal time (s)) in rats (mean ± SEM). 
 
Treatment        Dose (mg/kg, i.p.) 30 min 60 min 
Control  - 3.8 ± 0.7 4.2 ± 0.3 
ZS-4D 25 5.0 ± 0.7 5.4 ± 0.8 
 50 6.2 ± 0.6 6.6 ± 0.9 
 100 6.4 ± 0.7 5.6 ± 0.9 




Table 5. Effect of Zizyphus spina-christi ZS-4D fraction on egg albumin-induced paw oedema in rats. 
 
Experimental time (min) Treatment Dose 
(mg/kg,i.p.) 20 40 60 80 100 120 
Control  0.134±0.04   0.158±0.04    0.188±0.03    0.208±0.03   0.222±0.03   0.244±0.03 
ZS-4D 25 0.160±0.05 0.154±0.06 0.135±0.05 0.134±0.05 0.130±0.05 0.114±0.05 
 50 0.136±0.04   0.130±0.04    0.100±0.04     0.116±0.03   0.124±0.03   0.108±0.04 
  100 0.140±0.04   0.120±0.04 0.118±0.04 0.106±0.04 0.114±0.04 0.102±0.03 
ASA 100 0.132±0.04   0.122±0.04    0.112±0.04     0.110±0.04   0.116±0.04   0.098±0.03 
 




the first phase is dependent on peripheral inflammation 
and changes in central procession due to chemical med-
iators release from damaged cells that stimulate 
nociception and thus induced pain (Hunskaar and Hole, 
1987). In general, the test measures the response to a 
long lasting nociceptive stimulus similar to clinical pain 
(Tjolsen et al., 1992) and is recommended as a tool in 
basic pain research for studying the mechanisms of anal-
gesic agents (Hunskaar and Hole, 1987) because of its 
connection to tissue injury (Tjolsen et al., 1992). Agents 
that act primarily on the CNS inhibit both phases equally 
while peripherally acting drugs inhibit the late phase. The 
ability of the fraction to inhibit both phases of the formalin 
test indicates its involvement in both central and periphe-
rally mediated activity, probably by prostaglandin synthe-
sis inhibition, as well as central inhibition mechanism. 
This observation is further collaborated by the fraction’s 
ability to give a potent test on the mechanical model 
using analgesy-meter. The meter exerts force at a const-
antly increased rate on rat paw monitored by a pointer 
moving along a linear scale. It is a modification (Vongtau 
et al., 2004) of the Randall-Selitto (1957) test for measu-
ring analgesic activity based on the principle that inflam-
mation increases the sensitivity to nociception and this 
sensitivity is susceptible to modification by analgesics 
(Vogel and Vogel, 1997). The fact that the fraction incre-
ases the threshold of the intact paw strengthens the 
evidence of peripheral and centrally mediated activity 
(Vogel and Vogel, 1997; Vongtau et al., 2004). The frac-
tion however failed to exhibit potent effect on the tail-flick 
test. The test is a standard method for investigating 
nociception and analgesic (D’Amour and Smith, 1941) 
that measures the response to a brief, noxious stimulus 
which appears to be spinal reflex that is modulated by 
supraspinal inhibitory mechanism. The test is selective 
for centrally acting analgesics (Ramabadran et al., 1989) 
indicative of morphine like effect (Domer, 1990) and also 
like NSAIDs by inhibiting cycloxygenase in peripheral 
tissues thereby interfering with the mechanism of 
transduction in  primary afferent nociceptors (Fields, 
1987). The lack of potent effect on this test can therefore 
be  deduced   that  the  central  effect  observed  in  other 




models is devoid of specific morphine-like activity. This 
central action is presently not completely understood, but 
a preliminary work earlier done on the crude aqueous 
extract, shows that it has CNS activity that is sedative in 
nature (Adzu et al., 2002a). This might have been 
responsible for the central effects seen in the formalin 
and analgesy-meter tests.  
The fraction exhibited anti-inflammatory effect by 
inhibiting oedema induced by egg albumin in rat paw. 
The test is used as an in vivo model of inflammation to 
screen agents for anti-inflammatory effect (Akah et al., 
1993; Okoli et al., 2007) especially if inflammation wasn’t 
intended to be sustained for long (Williamson et al., 1996; 
Osadebe and Okoye et al., 2003). This may also be an 
immense advantage of the fraction since inflammatory 
diseases are currently treated with steroidal and NSAIDs, 
often associated with adverse effects (Fung and 
Kirschenbaum, 1999) hence the need for safe compou-
nds. Inflammation, a common occurrence in infective 
condition is a complex array of responses of tissue to 
injury (Vane and Bolting, 1995) which is usually assoc-
iated with pain as a secondary process, resulting from the 
release of algesic mediators (Hunskaar and Hole, 1987) 
with therapy often directed at the inflammation process. 
The anti-inflammatory effect of the fraction therefore was 
perhaps elicited through prostaglandins synthesis, the 
most frequently encountered mechanism of action amon-
gst anti-inflammatory drugs (Vane, 1971) that exert their 
effect through spectrum of different mode of actions 
(Samuelson et al., 1978). Conclusively, these observa-
tions provide evidence for analgesic and anti-
inflammatory activity of the fraction (ZS-4D) as the 
primary component of the plant material that exhibit pain 
relief action. It is difficult (at this stage) to pin down which 
of the phytochemical component is responsible for the 
activity of the fraction because of the little correlation 
between anti-inflammatory activity and the chemical 
nature of agents (Sertie et al., 1990). On the mechanism, 
the fraction exhibited activity similar to NSAIDs in a 
complementary manner, most likely through an intertwine 
action of blocking the stimulus propagation in the pain 
nervous fibers or decrease in the production of prostagl-
andins responsible for pain mediation (Matheus et al., 
2005). This shows, with some certainty, that the anti-
inflammatory component may in addition involve the 
observed peripheral analgesic activity (Spessoto et al., 
2003) and vice versa. Whereas all these explains the 
basis of the use of plant in the treatment of pain related 
cases, the fraction is worth probing for development into 
phytodrug with the hope that it will be in agreement with 
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